Form D · Business Services
Phoenix Pharms Capital Corp
Longmont, CO · CIK 0001594574
Offering snapshot reported Jul 2, 2014 · SEC filing
- Reported sold
- $126K Offering amount: $2.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 4, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2014 | Initial | $126,000 | No comparison | 6 | SEC filing |
| Mar 5, 2014 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Mar 4, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 17, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-220258
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Not Applicable | None |
Source: Form D, filed Jul 2, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lewis Humer | Director, Executive, Promoter |
| Richard Maher | Director |
| John Sanborn | Director, Executive |
| Martin Tindall | Director, Executive, Promoter |
Issuer details
Industry: Business Services (See others in industry)
Address:
2011 Ken Pratt Boulevard Suite 210
Longmont, CO, 80501
Longmont, CO, 80501